MCOPPB trihydrochlride

CAS No. 1108147-88-1

MCOPPB trihydrochlride( MCOPPB-trihydrochloride | MCOPPB tri-HCl )

Catalog No. M10404 CAS No. 1108147-88-1

MCOPPB 3hydrochloride is a nociceptin receptor agonist with pKi of 10.07.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 69 In Stock
10MG 122 In Stock
25MG 249 In Stock
50MG 402 In Stock
100MG 593 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MCOPPB trihydrochlride
  • Note
    Research use only, not for human use.
  • Brief Description
    MCOPPB 3hydrochloride is a nociceptin receptor agonist with pKi of 10.07.
  • Description
    MCOPPB 3hydrochloride is a nociceptin receptor agonist with pKi of 10.07; weaker activity at other opioid receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MCOPPB-trihydrochloride | MCOPPB tri-HCl
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1108147-88-1
  • Formula Weight
    518.01
  • Molecular Formula
    C26H43Cl3N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC1(N2CCC(N3C4=CC=CC=C4N=C3[C@H]5CNCCC5)CC2)CCCCCCC1.[H]Cl.[H]Cl.[H]Cl
  • Chemical Name
    1-[1-(1-Methylcyclooctyl)piperidin-4-yl]-2-[(3R)-piperidin-3-yl]benzimidazole trihydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hayashi, et al. Journal of Medicinal Chemistry (2009), 52(3), 610-625.
molnova catalog
related products
  • L-Menthol

    Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils.

  • Alvimopan

    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus.

  • Methylnaltrexone bro...

    A peripherally-acting μ-opioid antagonist that acts to reverse some of the side effects of opioid drugs such as constipation without affecting analgesia or precipitating withdrawals.